In the future, a precise understanding of the intracellular interaction between BDNF and GR signaling is needed to further clarify biological systems on the neurotrophin-dependent synaptic plasticity, and more importantly, this will point toward new therapeutic targets for neurodegenerative and psychiatric diseases. This evidence concerns the gene NR3C1 and psychiatric disorder.